Trial Profile
Efficiency of the Novel Hepatitis B Vaccine Sci-B-Vac in HIV Positive Patients, a Prospective Cohort Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 14 Nov 2016 According to a VBI Vaccines Inc.media release, final results anticipated in the second half of 2017.
- 14 Nov 2016 According to a VBI Vaccines Inc.media release, 88 patients enrolled till date.
- 14 Nov 2016 Interim results published in a VBI Vaccines Inc.media release.